BeiGene CCO Yin Min Detained Amid Investigation; Company Affirms Compliance Standards
On October 25, Yin Min, Chief Commercial Officer of BeiGene (NASDAQ: BGNE) Greater China, was...
SHA: 688217
Shanghai Rightongene Biotechnology Co., Ltd Executives Under Investigation by Chinese Authorities
Shanghai Rightongene Biotechnology Co., Ltd (SHA: 688217), a Chinese biopharmaceutical company, has announced that key...
Rightongene Bio Receives NMPA Approval for BCR-ABL P210 Fusion Gene Detection Kit
Shanghai Rightongene Biotechnology Co., Ltd (SHA: 688217), a biopharmaceutical company based in China, has announced...